| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 18, 2008
Revised on May 14, 2008
Accepted on May 14, 2008
From the Division of Cardiovascular Medicine (M.C.H.C., T.D.L., N.F., M.R.B.), and Department of Clinical Pharmacology (J.J.M., A.P.D.), University of Cambridge, Addenbrooke's Hospital, and Department of Histopathology (M.G.), Papworth Hospital, Cambridge, UK.
* To whom correspondence should be addressed. E-mail: mrb{at}mole.bio.cam.ac.uk.
Vascular smooth muscle cell (VSMC) accumulation is implicated in plaque development. In contrast, VSMC apoptosis is implicated in plaque rupture, coagulation, vessel remodeling, medial atrophy, aneurysm formation, and calcification. Although VSMC apoptosis accompanies multiple pathologies, there is little proof of direct causality, particularly with the low levels of VSMC apoptosis seen in vivo. Using a mouse model of inducible VSMC–specific apoptosis, we demonstrate that low-level VSMC apoptosis during either atherogenesis or within established plaques of apolipoprotein (Apo)E-/- mice accelerates plaque growth by two-fold, associated with features of plaque vulnerability including a thin fibrous cap and expanded necrotic core. Chronic VSMC apoptosis induced development of calcified plaques in younger animals and promoted calcification within established plaques. In addition, VSMC apoptosis induced medial expansion, associated with increased elastic lamina breaks, and abnormal matrix deposition reminiscent of cystic medial necrosis in humans. VSMC apoptosis prevented outward remodeling associated with atherosclerosis resulting in marked vessel stenosis. We conclude that VSMC apoptosis is sufficient to accelerate atherosclerosis, promote plaque calcification and medial degeneration, prevent expansive remodeling, and promote stenosis in atherosclerosis.
This article has been cited by other articles:
![]() |
Q. Ding, R. Gros, L. E. Limbird, J. Chorazyczewski, and R. D. Feldman Estradiol-mediated ERK phosphorylation and apoptosis in vascular smooth muscle cells requires GPR 30 Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1178 - C1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Chan, F. Lovren, Y. Pan, and S. Verma Nocturnal haemodialysis is associated with improved vascular smooth muscle cell biology Nephrol. Dial. Transplant., September 17, 2009; (2009) gfp495v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Y. Yip, J.-H. Chen, R. Zhao, and C. A. Simmons Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 936 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C.H. Clarke and M. R. Bennett Cause or Consequence: What Does Macrophage Apoptosis Do in Atherosclerosis? Arterioscler Thromb Vasc Biol, February 1, 2009; 29(2): 153 - 155. [Full Text] [PDF] |
||||
![]() |
M. Rattazzi, L. Iop, E. Faggin, E. Bertacco, G. Zoppellaro, I. Baesso, M. Puato, G. Torregrossa, G. P. Fadini, C. Agostini, et al. Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2165 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kavurma, N. Y. Tan, and M. R. Bennett Death Receptors and Their Ligands in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1694 - 1702. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |